Redacted SSJ.pdf

This document is a Notice of Intent to Award a sole source contract to Illumina, Inc. for the NextSeq 1000 Sequencing System. The Centers for Disease Control and Prevention (CDC) intends to award this firm fixed-price contract under the authority of FAR 13.106-1(b) and 41 U.S.C. 3304(a)(1). The NextSeq 1000 is an automated DNA sequencing system that will replace the current Illumina MiSeq system used by the CDC. The NextSeq 1000 offers a cost-effective alternative with higher throughput and lower reagent costs compared to the MiSeq. Interested parties may respond within 3 days to be considered, but this is not a competitive solicitation. The NAICS code for this procurement is 621511 - Medical Laboratories. The total value of the contract and any applicable set-asides are not provided.